Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $40,528 - $108,770
-29,800 Reduced 11.41%
231,400 $317,000
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $4,576 - $12,467
1,300 Added 0.5%
261,200 $979,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $88,356 - $153,328
-14,800 Reduced 5.39%
259,900 $2.55 Million
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $611,489 - $1.03 Million
-74,300 Reduced 21.29%
274,700 $2.29 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $948,147 - $1.34 Million
95,100 Added 37.46%
349,000 $4.64 Million
Q1 2023

May 15, 2023

SELL
$7.94 - $12.02 $350,154 - $530,082
-44,100 Reduced 14.8%
253,900 $2.94 Million
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $1.46 Million - $2.89 Million
257,800 Added 641.29%
298,000 $2.44 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $5,109 - $11,141
-1,300 Reduced 3.13%
40,200 $233,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $564M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.